RSS Subscribe to our Nanotechnology Business News feed

Celator Pharmaceuticals Presents New Data on Two Nano-Scale Delivery Platforms

Celator Pharmaceuticals today announced data from animal studies demonstrating the superior bone marrow uptake of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection, its lead clinical-stage program, as well as the enhanced circulation kinetics and efficacy of its preclinical hydrophobic docetaxel prodrug nanoparticle (HDPN) formulation were presented at the 101st Annual Meeting of the American Association for Cancer Research.

Apr 22nd, 2010

Read more

Malvern Instruments Celebrates Fifth Queen's Award

Malvern is to receive the 2010 Queen's Award for Enterprise in the category Innovation, in recognition of the company's continuous innovation and development of its award winning Zetasizer Nano range of particle characterization systems.

Apr 21st, 2010

Read more